RecallDepth
Class II Ongoing

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01 (carton) NDC 65250-001-01 (vial) with Diluent 5 mL Sterile single-use vial, Rx Only, Mfd. for: Pacira Pharmaceuticals, Inc. NDC 65250-002-01

This recall is currently active, issued July 3, 2024. It was issued by Pacira Pharmaceuticals, Inc..

Company
Pacira Pharmaceuticals, Inc.
Recall Initiated
June 12, 2024
Posted
July 3, 2024
Recall Number
D-0567-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
40,517 kits
Firm Location
San Diego, CA, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C

Distribution

US Nationwide.

Lot / Code Info

Lot 23-9006; Expiry Date: MAR 2025

More recalls by Pacira Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls